Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study

Abstract

Background A higher risk of suicidal ideation associated with self-report of Coronavirus Disease 2019 (COVID-19)-like symptoms or COVID-19 infection has been observed in cross-sectional studies, but evidence from longitudinal studies remains limited. The aims of this study were 2-fold: (1) to explore if self-reported COVID-19-like symptoms in 2020 were associated with suicidal ideation in 2021; (2) to explore if the association also existed when using a biological marker of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in 2020. Methods and findings A total of 52,050 participants from the French EpiCov cohort were included (median follow-up time = 13.7 months). In terms of demographics, 53.84% were women, 60.92% were over 45 years old, 82.01% were born in mainland France from parents born in mainland France, and 59.38% completed high school. COVID-19-like symptoms were defined as participant report of a sudden loss of taste/smell or fever alongside cough, shortness of breath, or chest oppression, between February and November 2020. Symptoms were self-reported at baseline in May 2020 and at the first follow-up in Autumn 2020. Serology-confirmed SARS-CoV-2 infection in 2020 was derived from Spike protein ELISA test screening in dried-blood-spot samples. Samples were collected from October 2020 to March 2021, with 94.4% collected in 2020. Suicidal ideation since December 2020 was self-reported at the second follow-up in Summer 2021. Associations of self-reported COVID-19-like symptoms and serology-confirmed SARS-CoV-2 infection in 2020 with suicidal ideation in 2021 were ascertained using modified Poisson regression models, weighted by inverse probability weights computed from propensity scores. Among the 52,050 participants, 1.68% [1.54% to 1.82%] reported suicidal ideation in 2021, 9.57% [9.24% to 9.90%] had a serology-confirmed SARS-CoV-2 infection in 2020, and 13.23% [12.86% to 13.61%] reported COVID-19-like symptoms in 2020. Self-reported COVID-19-like symptoms in 2020 were associated with higher risks of later suicidal ideation in 2021 (Relative Riskipw [95% CI] = 1.43 [1.20 to 1.69]), while serology-confirmed SARS-CoV-2 infection in 2020 was not (RRipw = 0.89 [0.70 to 1.13]). Limitations of this study include the use of a single question to assess suicidal ideation, the use of self-reported history of mental health disorders, and limited generalizability due to attrition bias. Conclusions Self-reported COVID-19-like symptoms in 2020, but not serology-confirmed SARS-CoV-2 infection in 2020, were associated with a higher risk of subsequent suicidal ideation in 2021. The exact role of SARS-CoV-2 infection with respect to suicide risk has yet to be clarified. Including mental health resources in COVID-19-related settings could encourage symptomatic individuals to care for their mental health and limit suicidal ideation to emerge or worsen.

Etiology and mortality of patients with altered level of consciousness in the emergency room: a multicenter analysis before and after the coronavirus disease 2019 outbreak

“…Regarding Toxic, according to the ALC-10 classi cation criteria, it encompasses ALCs caused by ingestion or inhalation of toxic materials (alcohol, insecticides ingestion, or adverse drug reactions), regardless of intent. It is well known that depression and suicide increased in AC [31][32][33][34][35]. Based on the authors' experience in the ER, there has been an increase in binge drinking or drug administration associated with feelings of hopelessness or suicidal intentions after the onset of COVID-19.…”

Reimagining the journey to recovery: The COVID-19 pandemic and global mental health

“…First, these papers demonstrate that the increases in prevalence of mental health problems expectedly were primarily concentrated in mood and anxiety conditions, but not severe mental health problems [ 8 – 13 ], and, some conditions even showed a decline or inconclusive findings (for example, self-harm was associated with self-reported symptoms but not serology confirmed infection in one study) [ 14 ]. Importantly, while one systematic review reported that symptoms of mood and anxiety problems increased in the first 6 months after the onset of the pandemic, the picture is less clear when participants are followed over longer periods and some changes may have been transient [ 15 – 17 ].…”